Last updated on June 2018

A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (ECHO-208)

Brief description of study

The purpose of this study is to determine the safety, tolerability, and efficacy of epacadostat when given in combination with nivolumab and ipilimumab, and in combination with nivolumab and lirilumab, in subjects with advanced or metastatic malignancies.

Clinical Study Identifier: TX206429

Find a site near you

Start Over

Duke University Medical Center

Located in: Durham, North Carolina USA
  Connect »

John Wayne Cancer Institute

Located in: Santa Monica, California USA
  Connect »